 Biological drugs have greatly improved the treatment of chronic inflammatory skin conditions, with a growing number of investigational drugs and small molecule inhibitors emerging as potential future prospects in the treatment of these diseases. This article was offered by Ichiyo, Astrid Helen Ravn Jorgensen and Simon Francis Thompson.